top of page
Green Circle Wellness

Low Dose Immunotherapy (LDI): What It Is and What to Ask

Nov 5
8 min read

Amber vial and dropper on a clinic counter

Low dose immunotherapy (LDI) is an approach in which practitioners give very small doses of allergens or microbial antigens, with the goal of helping the immune system become less reactive. The American Academy of Environmental Medicine describes it as small doses of allergens or internal microbial antigens used to help retrain immune tolerance. It is used mainly in integrative and functional medicine for allergies and chronic, immune-related problems. The name also appears in cancer research, where it means something quite different. This guide separates the two, explains what is and is not known, and lists what to discuss with a licensed clinician before you consider it.



TL;DR

 

  • LDI (also searched as LDI therapy) uses tiny, individualized doses of antigens such as foods, pollens, molds or microbes, with the aim of calming an overactive immune response.

  • It is not the same as standard allergy shots, and it is not the same as low-dose cancer immunotherapy or low-dose interleukin-2 (IL-2), which are separate treatments with their own trials.

  • The strongest published trial data in the “low-dose” immune field concern IL-2 drugs, not individualized LDI antigen drops or injections.

  • Treatment is usually gradual, with dose adjustments based on how you respond, so a clinician who has time to follow you closely matters.

  • Keep your established care in place, and talk with your physician before starting anything new, especially with an autoimmune disease.

 

Table of Contents

 

 

What low dose immunotherapy means

 

The phrase covers three different things, and search results mix them together.

 

1. LDI in integrative medicine. Practitioners prepare highly diluted antigens, often based on your history and testing, and give them by injection or other routes at intervals. AAEM groups this with low dose allergen (LDA) therapy. AAEM describes LDA as extremely low doses of allergens combined with beta-glucuronidase, while LDI uses small doses of allergens or internal microbial antigens. The stated aim is to retrain tolerance rather than to suppress the immune system.

 

2. Low-dose immunotherapy in oncology. Here, researchers ask whether approved immunotherapy drugs can be given at smaller doses without losing effectiveness, which could lower costs and immune-related toxicity. That is a question about drug dosing in cancer, not an allergy or autoimmune protocol.

 

3. Low-dose IL-2. Interleukin-2 is a signaling protein. At low doses it can favor regulatory T cells, the cells that help keep immune reactions in check. It is a pharmaceutical approach, studied in autoimmune disease, and distinct from antigen-based LDI.

 

If a page you read uses “low dose immunotherapy” and talks about survival in head and neck cancer, it is the second meaning. If it talks about drops, syringes and food or mold sensitivities, it is the first.


What low dose immunotherapy means

How LDI is proposed to work

 

The idea behind LDI is tolerance. In allergy, the immune system reacts strongly to something harmless. In some chronic conditions, practitioners propose that the immune system is reacting to food antigens, environmental exposures or microbes that keep it activated. Giving a very small amount of the relevant antigen is intended to nudge the response toward tolerance instead of reaction.

 

This is a practitioner-proposed mechanism. It is worth knowing how it compares with the best-understood relative of the idea, conventional allergen immunotherapy.

 

How it differs from standard allergen immunotherapy

 

Conventional allergen immunotherapy (allergy shots or sublingual tablets and drops) uses defined allergen extracts and standardized protocols. The Australasian Society of Clinical Immunology and Allergy notes that it may be considered for allergic rhinitis and allergic asthma when symptoms relate to allergen exposure, specific IgE to the relevant allergen is present, and medication is inadequate or poorly tolerated. The same guide says it reduces, but does not eliminate, allergic reactions.

 

Two features stand out:

 

 

LDI, by contrast, uses individualized preparations and dose adjustments guided by symptoms. The two are not interchangeable, and one does not validate the other.

 

What the evidence shows

 

Honest framing helps here. The research that most often gets cited in the “low-dose” space concerns other treatments.

 

Low-dose IL-2 in autoimmune disease

 

The clearest controlled data are for low-dose IL-2. In a 2022 randomized trial of 60 people with primary Sjögren syndrome, 66.7% of those receiving low-dose IL-2 reached at least a 3-point ESSDAI reduction at week 24, versus 26.7% on placebo, with no severe adverse events observed. A 2019 meta-analysis of 24 randomized trials with 1,321 patients found ultra-low-dose subcutaneous recombinant IL-2 generally well tolerated, with no symptomatic venous thromboembolism reported.


Week 24 response rates for IL-2 and placebo

The biology is also being mapped. Low-dose IL-2 stimulates regulatory T cells and may limit the differentiation of cells that drive inflammation. In people with type 1 diabetes, one study found regulatory T cells were roughly 15 to 20 times more sensitive to IL-2 than effector or memory T cells, which is why low doses can be selective.

 

These results apply to recombinant IL-2, a drug given under specialist supervision. They are not evidence for individualized antigen drops or injections, and they should not be read that way.

 

Low-dose checkpoint inhibitors in cancer

 

In oncology, a randomized trial in India found that adding nivolumab 20 mg every 3 weeks to a methotrexate, celecoxib and erlotinib regimen prolonged overall survival in advanced head and neck cancer. One-year survival rose from 16.3% to 43.4% in the low-dose arm. That was a palliative setting with a non-standard control arm. The authors of a review on the topic say further well-designed prospective studies, including a large phase III non-inferiority study, are needed.

 

What this means for LDI

 

Putting it plainly: the practitioner community describes LDI as a way to retrain immune tolerance, and clinicians who use it report their experience with patients. Large controlled trials of individualized LDI itself are not part of the sources above. If you are weighing it, treat it as a practitioner-guided approach, ask what outcomes your clinician tracks, and keep it alongside, not instead of, established treatment.

 

What treatment usually looks like

 

Protocols differ by practitioner, so confirm the details with the clinic you are considering. In general, an LDI course follows this pattern:

 

  1. History and testing. A clinician reviews your symptoms, exposures, medications and prior testing. Be clear on what each test can and cannot show; IgG food tests cannot diagnose allergy, for example.

  2. Preparation of doses. Antigens are diluted and compounded for you. Ask who prepares them and under what quality standards.

  3. Start low. Initial doses are chosen to be small, because sensitivity varies from person to person.

  4. Track and adjust. You note symptoms between doses. The clinician lengthens the interval or changes the dilution based on how you respond.

  5. Review. Over months, you and your clinician decide whether it is helping and whether to continue, change or stop.

 

The common thread is time. The protocol depends on careful symptom tracking and follow-up, which is hard to do in a ten-minute visit.

 

Safety and who should talk to a doctor first

 

Any therapy that stimulates or modulates the immune system deserves a medical conversation first. Specific situations to raise with a licensed physician:

 

  • A diagnosed autoimmune disease. Tell your rheumatologist, endocrinologist or gastroenterologist before adding any immune-directed therapy, and do not stop prescribed medicines on your own.

  • Suspected true allergy with severe reactions. If you have had hives with breathing trouble, throat swelling, or anaphylaxis, see a board-certified allergist/immunologist for confirmed testing and an emergency plan, including epinephrine if prescribed.

  • Asthma. Uncontrolled asthma raises the stakes for any allergen exposure. Review your plan with your physician first.

  • Pregnancy, children, or immunosuppressive medicines. Ask the specialist who manages those conditions whether any change is appropriate.

  • Cancer treatment. Never combine unproven immune therapies with cancer immunotherapy or chemotherapy without your oncologist’s agreement.

 

A good sign in any clinic is a clinician who asks for your records, coordinates with your other doctors, and tells you what a symptom flare after a dose should prompt you to do, including when to call.

 

Questions to ask before you start

 

  • What exactly will be in my doses, and how are they prepared?

  • What is the goal, and how will we measure it in the first three to six months?

  • What happens if my symptoms flare, and who do I call?

  • How does this fit with my current medicines and specialists?

  • What is the total cost, and what does it include?

 

Clear, unhurried answers are a better guide than any promise of results.

 

Perspective: root causes need time and a team

 

We see many people arrive with a long list of symptoms and a longer list of things they have already tried. Some have autoimmune disease. Some have reactions to foods or the environment that no one has explained. Many are searching for terms like LDI because they want a treatment that goes beyond symptom control.   Our view is that the approach matters more than the label. Root-cause health work starts with a long conversation, personalized testing and a plan built around biomarkers and your history. It also depends on a team that talks to each other, so that your allergy, gut, hormone and nutrition questions are not handled in isolation.   That is how we practice at Green Circle: evidence-based integrative care, ample appointment time, and treatment plans tailored to the individual. If you are curious about immune-focused options, we would rather help you understand the evidence, including where it is strong and where it is still developing, than hand you a quick answer.   Dina

 

How we can help

 

If you are in Chicago, or in Illinois for virtual consults, our clinicians can review your history and testing and talk through immune and allergy-related options with you. Our Advanced Allergy Therapy service and our Functional Medicine care are designed for people who want a thorough, personalized look at what may be driving their symptoms.


Greencirclewellness

You can see everything we offer on our services page or read how we work on our approach page. If histamine reactions are part of your picture, our guide to the histamine intolerance diet is a good place to start, and our article on thymosin alpha 1 and the 2024 to 2025 evidence covers another immune-focused topic.

 

FAQ

 

What is LDI therapy?

 

LDI stands for low dose immunotherapy. Practitioners use small doses of allergens or microbial antigens to try to help the immune system regain tolerance. It is mostly offered in integrative and functional medicine settings and differs from standard allergy shots.

 

Is low dose immunotherapy the same as allergy shots?

 

No. Standard allergen immunotherapy uses defined extracts for a confirmed IgE-mediated allergy, with protocols that include a build-up and maintenance phase. LDI uses individualized preparations and adjusts doses based on your response, so the two should be discussed separately with your clinician.

 

Is there clinical evidence for LDI?

 

The best-controlled data in the low-dose immune field concern low-dose IL-2, a pharmaceutical, including a randomized trial in Sjögren syndrome. Those results do not transfer to individualized LDI antigen therapy. Ask any provider which outcomes they track for their patients.

 

Can I use LDI alongside my current treatment?

 

Many people keep established care in place while exploring integrative options, but that decision belongs with your physician. Share every medicine and supplement you take, and never stop prescribed treatment on your own.

 

Should I get tested before considering it?

 

Testing helps define what you are dealing with. A true allergy is confirmed with IgE-based testing and clinical history, while IgG results alone cannot diagnose allergy. A clinician can help you choose tests that answer your actual question.

 

Sources

 

Recommended

 

 

This article is for education only and is not medical advice.

 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page